BioMarin Pharmaceutical Inc. buy Oppenheimer Holdings Inc.
Start price
24.02.25
/
50%
€66.28
Target price
24.02.26
€93.59
Performance (%)
-20.31%
End price
25.02.26
€52.82
Summary
This prediction ended on 25.02.26 with a price of €52.82. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.31%. Oppenheimer_Holdings has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.129% | -0.129% | -10.727% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Oppenheimer_Holdings for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€53.20
24.02.26
24.02.26
€80.62
24.02.27
24.02.27
-12.71%
17.04.26
17.04.26
